These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 24940692)

  • 41. A high isoflavone diet decreases 5' adenosine monophosphate-activated protein kinase activation and does not correct selenium-induced elevations in fasting blood glucose in mice.
    Stallings MT; Cardon BR; Hardman JM; Bliss TA; Brunson SE; Hart CM; Swiss MD; Hepworth SD; Christensen MJ; Hancock CR
    Nutr Res; 2014 Apr; 34(4):308-17. PubMed ID: 24774067
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxidative modulation and inactivation of rabbit cardiac adenylate deaminase.
    Janero DR; Yarwood C
    Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):421-7. PubMed ID: 7887895
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mammalian-heart adenylate deaminase: cross-species immunoanalysis of tissue distribution with a cardiac-directed antibody.
    Thakkar JK; Janero DR; Sharif HM; Yarwood C
    Mol Cell Biochem; 1995 Apr; 145(2):177-83. PubMed ID: 7675037
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular and kinetic alterations of muscle AMP deaminase during chronic creatine depletion.
    Rush JW; Tullson PC; Terjung RL
    Am J Physiol; 1998 Feb; 274(2):C465-71. PubMed ID: 9486137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in AMP deaminase activities in the hearts of diabetic rats.
    Jenkins RL; McDaniel HG; Atkins L
    Biochim Biophys Acta; 1991 Apr; 1077(3):379-84. PubMed ID: 2029537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of AMP deaminase by phosphoinositides.
    Sims B; Mahnke-Zizelman DK; Profit AA; Prestwich GD; Sabina RL; Theibert AB
    J Biol Chem; 1999 Sep; 274(36):25701-7. PubMed ID: 10464307
    [TBL] [Abstract][Full Text] [Related]  

  • 47. AMP deaminase 1 gene polymorphism and heart disease-a genetic association that highlights new treatment.
    Smolenski RT; Rybakowska I; Turyn J; Romaszko P; Zabielska M; Taegtmeyer A; Słomińska EM; Kaletha KK; Barton PJ
    Cardiovasc Drugs Ther; 2014 Apr; 28(2):183-9. PubMed ID: 24431031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular forms of human heart muscle AMP deaminase.
    Nowak G; Kaletha K
    Biochem Med Metab Biol; 1991 Oct; 46(2):263-6. PubMed ID: 1782016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protection of mouse heart against hypoxic damage by AMP deaminase inhibition.
    Borkowski T; Slominska EM; Orlewska C; Chlopicki S; Siondalski P; Yacoub MH; Smolenski RT
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):449-52. PubMed ID: 20544535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and Biochemical Testing of 3-(Carboxyphenylethyl)imidazo[2,1-f][1,2,4]triazines as Inhibitors of AMP Deaminase.
    Lindell SD; Maechling S; Sabina RL
    ACS Med Chem Lett; 2010 Sep; 1(6):286-9. PubMed ID: 24900209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hypotropic diet and cardiac function].
    CONTI C
    Boll Soc Ital Biol Sper; 1947 Dec; 23(12):1252-5. PubMed ID: 18856385
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of pharmacological AMP deaminase inhibition and Ampd1 deletion on nucleotide levels and AMPK activation in contracting skeletal muscle.
    Plaideau C; Lai YC; Kviklyte S; Zanou N; Löfgren L; Andersén H; Vertommen D; Gailly P; Hue L; Bohlooly-Y M; Hallén S; Rider MH
    Chem Biol; 2014 Nov; 21(11):1497-1510. PubMed ID: 25459662
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of AMP deaminase in diabetic cardiomyopathy.
    Miura T; Kouzu H; Tanno M; Tatekoshi Y; Kuno A
    Mol Cell Biochem; 2024 Feb; ():. PubMed ID: 38386218
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simple oxygraphic analysis for the presence of adenylate kinase 1 and 2 in normal and tumor cells.
    Klepinin A; Ounpuu L; Guzun R; Chekulayev V; Timohhina N; Tepp K; Shevchuk I; Schlattner U; Kaambre T
    J Bioenerg Biomembr; 2016 Oct; 48(5):531-548. PubMed ID: 27854030
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Per-Arnt-Sim Kinase (PASK): An Emerging Regulator of Mammalian Glucose and Lipid Metabolism.
    Zhang DD; Zhang JG; Wang YZ; Liu Y; Liu GL; Li XY
    Nutrients; 2015 Sep; 7(9):7437-50. PubMed ID: 26371032
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activity of AMP-regulated protein kinase and AMP-deaminase in the heart of mice fed high-fat diet.
    Rybakowska I; Slominska EM; Romaszko P; Lipiński M; Zukowska P; Smolenski RT
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):347-52. PubMed ID: 24940692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AMP-regulated protein kinase activity in the hearts of mice treated with low- or high-fat diet measured using novel LC-MS method.
    Rybakowska IM; Slominska EM; Romaszko P; Olkowicz M; Kaletha K; Smolenski RT
    Mol Cell Biochem; 2015 Jun; 404(1-2):5-10. PubMed ID: 25711403
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of AMP deaminase activity does not improve glucose control in rodent models of insulin resistance or diabetes.
    Admyre T; Amrot-Fors L; Andersson M; Bauer M; Bjursell M; Drmota T; Hallen S; Hartleib-Geschwindner J; Lindmark B; Liu J; Löfgren L; Rohman M; Selmi N; Wallenius K
    Chem Biol; 2014 Nov; 21(11):1486-96. PubMed ID: 25459661
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.